Skip to main content
. 2021 Jul 1;22(13):7138. doi: 10.3390/ijms22137138

Table 2.

Drugs decreasing macrophage and mast cell infiltration and activation.

Reference Drug Effect Endometriosis Source Experimental Model
Haber et al., 2009 [102] Liposomal bisphosphonate Decline in endometriotic lesion volume Rodent (rat) Autotransplantation rat model
less macrophage infiltration
Foster et al., 2019 [96] Liposomal clodronate Less macrophage infiltration Human (pelvic endometriotic lesions) In vitro culture; xenotransplantation murine model
Decrease in IGF-1 expression
Linsitinib Attenuation of hyperalgesia
Ihara et al., 2004 [103] Leukotriene receptor antagonists Lower stromal proliferation rates Rodent (rat) Autotransplantation rat model
Decline in mast cell infiltration and activation
Guney et al., 2008 [104] Melatonin Decline in endometriotic lesion volume Rodent (rat) Autotransplantation rat model
Increased SOD and CAT activity
Lower MDA levels
Yildirim et al., 2009 [105] Melatonin Decline in endometriotic lesion volume Rodent (rat) Autotransplantation rat model
Increased SOD and CAT activity
Schwertner et al., 2013 [106] Melatonin Alleviation of chronic pain Human (pelvic endometriotic lesions) Endometriosis patients with chronic pain
Improvement in dysmenorrhea and dyspareunia
Improvement in dyschezia and dysuria
Lower BDNF levels
Iuvone et al., 2016 [107] PEA Decrease in mast cell numbers Rodent (rat) Autotransplantation rat model
Decline in endometriotic lesion volume
Idraccolo et al., 2017 [108] PEA + polydatin Alleviation of chronic pain Human (pelvic endometriotic lesions) Endometriosis patients with chronic pain
Improvement in dysmenorrhea and dyspareunia
No improvement in dyschezia

PEA, ultramicronized palmitoylethanolamide; IGF-1, insulin growth factor 1; SOD, superoxide dismutase; CAT, catalase; MDA, malondialdehyde; BDNF, brain-derived neurotrophic factor.